ArticlePharmaceutics2023

Use of In Vitro Dynamic Colon Model (DCM) to Inform a Physiologically Based Biopharmaceutic Model (PBBM) to Predict the In Vivo Performance of a Modified-Release Formulation of Theophylline.

Konstantinos Stamatopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.